Steel Therapeutics, founded in Iowa, is a pharmaceutical company dedicated to increasing access to life-changing therapies with proven efficacy from compounding pharmacies. Their core mission is to transform the availability of compounded medications by pursuing FDA approval, ensuring optimized delivery and known therapeutic benefits. The company leverages the expertise of its founders, who have extensive experience in both retail compounding programs and advanced medical devices, to bridge the gap between innovative treatments and regulatory compliance.

Notable affiliated individuals include the founding team, who have a strong background in both pharmaceuticals and medical device innovation. Steel Therapeutics has made significant strides in the pharmaceutical industry by focusing on FDA approval for compounded medications, thereby enhancing their credibility and market reach. Their efforts have had a substantial impact on improving patient access to essential therapies, positioning them as a key player in the field of compounded pharmaceuticals.